1. Home
  2. CLOV vs ANIP Comparison

CLOV vs ANIP Comparison

Compare CLOV & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clover Health Investments Corp.

CLOV

Clover Health Investments Corp.

HOLD

Current Price

$4.69

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$84.44

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLOV
ANIP
Founded
2014
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
CLOV
ANIP
Price
$4.69
$84.44
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$2.90
$110.00
AVG Volume (30 Days)
8.9M
291.4K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
38.03
419.23
EPS
0.05
1.28
Revenue
$1,924,308,000.00
$206,547,000.00
Revenue This Year
$52.59
$21.01
Revenue Next Year
$15.37
$17.59
P/E Ratio
$93.20
$66.23
Revenue Growth
40.34
2.47
52 Week Low
$1.58
$62.61
52 Week High
$5.59
$99.50

Technical Indicators

Market Signals
Indicator
CLOV
ANIP
Relative Strength Index (RSI) 49.91 55.21
Support Level $1.96 $77.16
Resistance Level $5.18 $87.42
Average True Range (ATR) 0.28 2.46
MACD -0.12 0.15
Stochastic Oscillator 5.73 66.25

Price Performance

Historical Comparison
CLOV
ANIP

About CLOV Clover Health Investments Corp.

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: